Effect of Vitamin K Epoxide Reductase Complex 1 Polymorphism on Warfarin Dose Requirement among Patients in Tertiary Care Hospital.
Sahana Hadihalli Veeregowda, Bhuvana Krishnaswamy, Sharath Balakrishna
Abstract
Sahana Hadihalli Veeregowda, Bhuvana Krishnaswamy, Sharath Balakrishna
Abstract
BACKGROUND: polymorphism on the maintenance dose of warfarin. MATERIALS AND METHODS: gene polymorphism and warfarin maintenance dose was analyzed. RESULTS: = 0.0001). CONCLUSION: polymorphism alone influence 26.3% variability in warfarin dose and AA genotype patients required lower dose.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
BACKGROUND: polymorphism on the maintenance dose of warfarin. MATERIALS AND METHODS: gene polymorphism and warfarin maintenance dose was analyzed. RESULTS: = 0.0001). CONCLUSION: polymorphism alone influence 26.3% variability in warfarin dose and AA genotype patients required lower dose.
Key concepts: VKORC1, Vitamin K epoxide reductase, Warfarin, Genotyping, Genotype, CYP2C9, Internal medicine, Gastroenterology